Author:
Gyémánt N,Engi H,Schelz Z,Szatmári I,Tóth D,Fülöp F,Molnár J,de Witte P A M
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Betti M (1941). Org Synth Coll 1: 381–383
2. Chi KN, Chia SK, Dixon R, Newman MJ, Wacher VJ, Sikic B, Gelmon KA (2005) A phase I pharmacokinetic study of the P-glycoprotein inhibitor, ONT-093, in combination with paclitaxel in patients with advanced cancer. Invest New Drugs 23: 311–315
3. Cornwell MM, Pastan I, Gottesmann MM (1987) Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem 262: 2166–2170
4. Dantzig AH, Shepard RL, Cao J, Law KL, Ehlhardt WJ, Baughman TM, Bumol TF, Starling JJ (1996) Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropildibenzosuberan modulator, LY335979. Cancer Res 56: 4171–4179
5. Didziapetris R, Japertas P, Avdeef A, Petrauskas A (2003) Classification analysis of P-glycoprotein substrate specificity. J Drug Target 11: 391–406
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献